{"id":"NCT00321984","sponsor":"Takeda","briefTitle":"Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux Disease","officialTitle":"A Phase 3 Study to Evaluate the Efficacy and Safety of Dexlansoprazole MR (30 mg QD and 60 mg QD) Compared to Placebo on Symptom Relief in Subjects With Symptomatic Nonerosive Gastroesophageal Reflux Disease (GERD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-06","primaryCompletion":"2006-12","completion":"2006-12","firstPosted":"2006-05-04","resultsPosted":"2009-03-23","lastUpdate":"2011-04-28"},"enrollment":947,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Gastroesophageal Reflux Disease"],"interventions":[{"type":"DRUG","name":"Dexlansoprazole MR","otherNames":["TAK-390MR","Kapidex","Dexilant"]},{"type":"DRUG","name":"Dexlansoprazole MR","otherNames":["TAK-390MR","Kapidex","Dexilant"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Dexlansoprazole MR 30 mg QD","type":"EXPERIMENTAL"},{"label":"Dexlansoprazole MR 60 mg QD","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to assess the efficacy and safety of Dexlansoprazole modified release (MR) (30 mg once daily \\[QD\\] or 60 mg QD) compared to placebo in relief of daytime and nighttime heartburn over 4 weeks in subjects with symptomatic, nonerosive gastroesophageal reflux disease (GERD).","primaryOutcome":{"measure":"Percentage of Days With Neither Daytime Nor Nighttime Heartburn During Treatment as Assessed by Daily Electronic Diary-Median","timeFrame":"4 weeks","effectByArm":[{"arm":"Placebo QD","deltaMin":18.5,"sd":null},{"arm":"Dexlansoprazole MR 30 mg QD","deltaMin":54.9,"sd":null},{"arm":"Dexlansoprazole MR 60 mg QD","deltaMin":50,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.00001"},{"comp":"OG000 vs OG002","p":"<0.00001"},{"comp":"OG001 vs OG002","p":"0.72941"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":18},"locations":{"siteCount":153,"countries":["United States"]},"refs":{"pmids":["19392864","19735233","21129076","24118079","23451835"],"seeAlso":["http://general.takedapharm.com/content/file/pi.pdf?applicationcode=9efb34b3-fb69-4190-a2be-a90b8cb94e25&filetypecode=DEXILANTPI"]},"adverseEventsSummary":{"seriousAny":{"events":1},"commonTop":["Diarrhoea (Excluding Infective)","Nausea and Vomiting Symptoms","Headaches NEC"]}}